Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Ketamine as Adjuvant to Bupivacaine in TAP Block for Postoperative Analgesia
NCT07845643Phase 4Not yet recruiting
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Oct 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and ketamine in postoperative pain (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoint: Total Postoperative Morphine Consumption at 24 hours. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
dexmedetomidineketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07845643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07845643.